Novel mechanisms and devices to enable successful transdermal drug delivery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abramson, 1941, Skin reactions. XII. Patterns produced in the skin by electrophoresis of dyes, Arch. Dermatol. Syphilol., 44, 190, 10.1001/archderm.1941.01500020045003
Agarwal, 2000, The pilosebaceous unit: a pivotal route for topical drug delivery, Methods Find Exp. Clin. Pharmacol., 22, 129, 10.1358/mf.2000.22.2.796082
Allec, 1997, Skin distribution and pharmaceutical aspects of adapalene gel, J. Am. Acad. Dermatol., 36, S119, 10.1016/S0190-9622(97)70055-0
Asano, 1997, Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats, Biol. Pharm. Bull., 20, 288, 10.1248/bpb.20.288
Asbill, 2000, Enhancement of transdermal drug delivery: chemical and physical approaches, Crit. Rev. Ther. Drug Carrier Sys., 17, 621
Asbill, 2000, Percutaneous penetration enhancers: local versus transdermal activity, PSTT, 3, 36
Aungst, 1990, Contributions of drug solubilisation, partitioning, barrier disruption and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines, Pharm. Res., 7, 712, 10.1023/A:1015859320604
Badkar, 1999, Enhancement of transdermal iontophoretic delivery of a liposomal formulation of colchicine by electroporation, Drug Del., 6, 111, 10.1080/107175499267039
Banga, 1998
Banga, 1999, Iontophoresis and electroporation: comparisons and contrasts, Int. J. Pharm., 179, 1, 10.1016/S0378-5173(98)00360-3
Barry, 1983
Barry, 1988, Action of skin penetration enhancers — the lipid protein partitioning theory, Int. J. Cosmet. Sci., 10, 281, 10.1111/j.1467-2494.1988.tb00028.x
Barry, 1991, Lipid–protein partitioning theory of skin penetration enhancement, J. Control. Rel., 15, 237, 10.1016/0168-3659(91)90115-T
Barry, 1995, Permeation enhancement through skin, Vol. 11, 449
Bashir, 2001, Physical and physiological effects of stratum corneum tape stripping, Skin Res. Technol., 7, 40, 10.1034/j.1600-0846.2001.007001040.x
Bath, 2000, Visualisation and analysis of electroosmotic flow in hairless mouse skin, Pharm. Res., 17, 471, 10.1023/A:1007589306661
Bhatia, 1998, Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies, Pharm. Res., 15, 1857, 10.1023/A:1011906022903
Bhatia, 1998, Synergistic effect of iontophoresis of a series of fatty acid on LHRH permeability through human skin, J. Pharm. Sci., 87, 462, 10.1021/js970301f
Bommannan, 1994, Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro, Pharm. Res., 11, 1809, 10.1023/A:1018983804635
Brand, 1998, Effects of size and sequence on the iontophoretic delivery of oligonucleotides, J. Pharm. Sci., 87, 49, 10.1021/js9701871
Bucks, 1989, Occlusion does not uniformly enhance penetration in vivo, 77
Burkoth, 1999, Transdermal and transmucosal powdered drug delivery, Crit. Rev. Ther. Drug Carrier Sys., 16, 331, 10.1615/CritRevTherDrugCarrierSyst.v16.i4.10
Burnette, 1987, Characterisation of the permselective properties of excised human skin during iontophoresis, J. Pharm. Sci., 76, 765, 10.1002/jps.2600761003
Burnette, 1988, Characterisation of the pore transport properties and tissue alteration of excised human skin during iontophoresis, J. Pharm. Sci., 77, 132, 10.1002/jps.2600770208
Byl, 1995, The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis, Physica Ther., 75, 539, 10.1093/ptj/75.6.539
Camel, 1995, Ultrasound, 369
Cantrel, 2000, Transdermal extraction of interstitial fluid by low-frequency ultrasound quantified with (H2O)–H3 as a tracer molecule, J. Pharm. Sci., 89, 1170, 10.1002/1520-6017(200009)89:9<1170::AID-JPS9>3.0.CO;2-9
Cevc, 1996, Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 13, 257, 10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.30
Cevc, 1992, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradient and hydration force, Biochim. Biophys. Acta, 1104, 226, 10.1016/0005-2736(92)90154-E
Cevc, 1997, Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo, J. Control. Rel., 45, 211, 10.1016/S0168-3659(96)01566-0
Cevc, 1996, The skin: a pathway for systemic treatment with patches and lipid-based carriers, Adv. Drug Del. Rev., 18, 349, 10.1016/0169-409X(95)00091-K
Cevc, 1995, Transdermal drug carriers: basic properties, optimisation and transfer efficiency in the case of epicutaneously applied peptides, J. Control. Res., 36, 3, 10.1016/0168-3659(95)00056-E
Cevc, G., Schatzlein, A., Gebauer, D., Blume, G., 1993. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug carriers, transfersome. In: Brain, K.R., James, V.A., Walters, K.A. (Eds.) Prediction of Percutaneous Penetration. 3rd International Conference. Vol. 3b. STS Publishing, Cardiff, 226–236.
Chang, 2000, The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones, J. Control. Res., 66, 127, 10.1016/S0168-3659(99)00262-X
Cheng, 1999, Enhancement of skin permeation, 5
Cheng, 1999, Charged microbeads are not transported across the human stratum corneum in vitro by short high-voltage pulses, Bioelectrochem. Bioenerg., 48, 181, 10.1016/S0302-4598(99)00007-0
Chiang, 1989, Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations, Int. J. Pharm., 55, 229, 10.1016/0378-5173(89)90046-X
Chiang, 1998, Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide, Drug Devel. Ind. Pharm., 24, 431, 10.3109/03639049809085640
Choi, 1999, The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis, Skin Pharmacol. Appl. Skin Physiol., 12, 326, 10.1159/000029894
Coldman, 1969, Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles, J. Pharm. Sci., 58, 1098, 10.1002/jps.2600580912
Cornwell, 1994, Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil, J. Pharm. Pharmacol., 46, 261, 10.1111/j.2042-7158.1994.tb03791.x
Cornwell, 1996, Modes of action of terpene penetration enhancers in human skin: differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies, Int. J. Pharm., 127, 9, 10.1016/0378-5173(95)04108-7
Cornwell, 1994, Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment, J. Pharm. Pharmacol., 46, 938, 10.1111/j.2042-7158.1994.tb03248.x
Cullander, 1991, Sites of iontophoretic current flow into the skin: identification and characterisation with the vibrating probe electrode, J. Invest. Dermatol., 97, 55, 10.1111/1523-1747.ep12478060
Curdy, 2001, Non-invasive assessment of the effects of iontophoresis on human skin in vivo, J. Pharm. Pharmacol., 53, 769, 10.1211/0022357011776117
Davis, 1991, Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate, Int. J. Pharm., 76, 1, 10.1016/0378-5173(91)90337-N
Dayan, 2000, Carriers for skin delivery of trihexyphenidyl HCI: ethosomes vs. liposomes, Biomaterials, 21, 1879, 10.1016/S0142-9612(00)00063-6
Degano, 1998, Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect (R) system, Vaccine, 16, 394, 10.1016/S0264-410X(97)00202-8
Delgado-Charro, 1994, Characterisation of convective solvent flow during iontophoresis, Pharm. Res., 11, 929, 10.1023/A:1018910715229
El Maghraby, 1999, Skin delivery of estradiol from deformable and traditional liposomes: mechanistic studies, J. Pharm. Pharmacol., 51, 1123, 10.1211/0022357991776813
El Maghraby, 2000, Skin delivery of estradiol from ultradeformable liposomes: refinement of surfactant concentration, Int. J. Pharm., 196, 63, 10.1016/S0378-5173(99)00441-X
El Maghraby, 2000, Skin delivery of estradiol from lipid vesicles: importance of liposome structure, Int. J. Pharm., 204, 159, 10.1016/S0378-5173(00)00493-2
El Maghraby, G.M.M., Williams, A.C., Barry, B.W., 2001a. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol., in press.
El Maghraby, G.M.M., Williams, A.C., Barry, B.W., 2001b. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J. Pharm. Pharmacol., in press.
Fan, 1999, Immunization via hair follicles by topical application of naked DNA to normal skin, Nature Biotechnol., 17, 870, 10.1038/12856
Fang, 1999, Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers, Int. J. Pharm., 176, 157, 10.1016/S0378-5173(98)00301-9
Fresta, 1996, Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles, J. Drug Target, 4, 95, 10.3109/10611869609046267
Friedland, 2000, Skin care and the topical treatment of aging skin, Clin. Plastic Surg., 27, 501, 10.1016/S0094-1298(20)32756-5
Goodman, 1989, Lipid–protein partitioning (LPP) theory of skin enhancer activity: finite dose technique, Int. J. Pharm., 57, 29, 10.1016/0378-5173(89)90260-3
Grimmes, 1984, Pathways of ionic flow through human skin in vivo, Acta Derm. Venereol., 64, 93, 10.2340/00015555649398
Guo, 2000, Lecithin vesicular carriers for transdermal delivery of cyclosporin A, Int. J. Pharm., 194, 201, 10.1016/S0378-5173(99)00361-0
Gupta, 1998, Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system, J. Pharm. Sci., 87, 976, 10.1021/js970437d
Guy, 1998, Iontophoresis — recent developments, J. Pharm. Pharmacol., 50, 371, 10.1111/j.2042-7158.1998.tb06875.x
Hadgraft, 1999, Passive enhancement strategies in topical and transdermal drug delivery, Int. J. Pharm., 184, 1, 10.1016/S0378-5173(99)00095-2
Haigh, 1995, Hydration and topical corticosteroid absorption, 29
Henmi, 1994, Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base, Chem. Pharm. Bull., 42, 651, 10.1248/cpb.42.651
Henry, S., McAllister, D., Allen, M.G., Prauznitz, M.R., 1998. Microfabricated microneedles: a novel method to increase transdermal drug delivery, J. Pharm. Sci., 922–925.
Higuchi, 1960, Physical chemical analysis of percutaneous absorption process, J. Soc. Cosmetic Chemists, 11, 85
Higuchi, 1999, Mechanistic aspects of iontophoresis in human epidermal membrane, J. Control. Res., 62, 13, 10.1016/S0168-3659(99)00026-7
Hoffman, 2000, The hair follicle as a gene therapy target, Nature Biotechnol., 18, 20, 10.1038/71866
Hofmann, 1995, Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules, Bioelectrochem. Bioenerg., 38, 209, 10.1016/0302-4598(95)01827-2
Hollingsbee, 1965, Use of occluded hydrocolloid patches, 35
Hori, 1989, Classification of percutaneous penetration enhancers: a conceptual diagram, 197
Hori, 1990, Classification of penetration enhancers: a conceptual diagram, J. Pharm. Pharmacol., 42, 71, 10.1111/j.2042-7158.1990.tb05356.x
Hikima, 1998, The effect of ultrasound application on skin metabolism of prednisolone 21-acetate, Pharm. Res., 15, 1680, 10.1023/A:1011944209274
Iervolino, 2000, Membrane penetration enhancement of ibuprofen using supersaturation, Int. J. Pharm., 198, 229, 10.1016/S0378-5173(00)00346-X
Ilic, 1999, Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits, J. Control. Res., 61, 185, 10.1016/S0168-3659(99)00120-0
Ilic, 2001, Microfabrication of individual 200 μm diameter transdermal microconduits using high voltage pulsing in salicylic acid and benzoic acid, J. Invest. Dermatol., 116, 40, 10.1046/j.1523-1747.2001.00214.x
Jadoul, 1999, Effects of iontophoresis and electroporation on the stratum corneum — review of the biophysical studies, Adv. Drug Del. Rev., 35, 89, 10.1016/S0169-409X(98)00065-9
Jadoul, 1997, Electrically-enhanced transdermal delivery of domperidone, Int. J. Pharm., 154, 229, 10.1016/S0378-5173(97)00139-7
Johnson, 1996, Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery, J. Pharm. Sci., 85, 670, 10.1021/js960079z
Kang, 2000, Physicochemical studies of lidocaine–menthol binary systems for enhanced membrane transport, Int. J. Pharm., 206, 35, 10.1016/S0378-5173(00)00505-6
Kanikkannan, 2000, Structure–activity relationship of chemical penetration enhancers in transdermal drug delivery, Curr. Med. Chem., 7, 593, 10.2174/0929867003374840
Kemken, 1992, Influence of supersaturation on the thermodynamic effect of bupranolol after dermal administration using microemulsions as vehicle, Pharm. Res., 9, 554, 10.1023/A:1015856800653
Kondon, 1987, Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier, J. Pharmacobio-Dyn., 10, 587, 10.1248/bpb1978.10.587
Kondon, 1987, Enhancement of transdermal delivery by superfluous thermodynamic potential. II. In vitro–in vivo correlation of percutaneous nifedipine transport, J. Pharmacobio-Dyn., 10, 662, 10.1248/bpb1978.10.662
Kondon, 1987, Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats, J. Pharmacobio-Dyn., 10, 743, 10.1248/bpb1978.10.743
Kost, 1995, Phonophoresis, 2115
Kost, 1996, Synergistic effect of electric field and ultrasound on transdermal transport, Pharm. Res., 13, 633, 10.1023/A:1016070710397
Langer, 2000, Biomaterials in drug delivery and tissue engineering: one laboratory’s experience, Acc. Chem. Res., 33, 94, 10.1021/ar9800993
Le, 2000, Combined effect of low frequency ultrasound and iontophoresis: application for transdermal heparin delivery, Pharm. Res., 17, 1151, 10.1023/A:1026426317413
Lee, 1999, Topical drug delivery in humans with a single photomechanical wave, Pharm. Res., 16, 1717, 10.1023/A:1018954015441
Lin, 1997, The role of electroosmotic flow on in vitro transdermal iontophoresis, J. Control. Rel, 43, 23, 10.1016/S0168-3659(96)01468-X
Lipp, 1998, Selection and use of crystallisation inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids, J. Pharm. Pharmacol., 50, 1343, 10.1111/j.2042-7158.1998.tb03357.x
Lipp, 1999, Use of X-ray crystallography for the characterisation of single crystals grown in steroid containing transdermal drug delivery systems, Eur. J. Pharm. Biopharm., 47, 133, 10.1016/S0939-6411(98)00055-1
Liu, 1998, Non-invasive assessment and control of ultrasound-mediated membrane permeabilisation, Pharm. Res., 15, 918, 10.1023/A:1011984817567
Lombry, 2000, Transdermal delivery of macromolecules using skin electroporation, Pharm. Res., 17, 32, 10.1023/A:1007510323344
McAllister, 2000, Microfabricated microneedles for gene and drug delivery, Annu. Rev. Biomed. Eng., 2, 289, 10.1146/annurev.bioeng.2.1.289
Mazda, 1997, Preparation and characterisation of urea niosomes — in vitro and in vivo studies, STP Pharm. Sci., 7, 205
Meehan, 1997, A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules, J. Control. Rel., 46, 107, 10.1016/S0168-3659(96)01608-2
Megrab, 1995, Estradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation, J. Control. Rel., 36, 277, 10.1016/0168-3659(95)00062-D
Megwa, 2000, Ion-pair formation as a strategy to enhance topical delivery of salicylic acid, J. Pharm. Pharmacol., 52, 919, 10.1211/0022357001774804
Megwa, 2000, Effect of ion pairing with alkylamines on the in vitro dermal penetration and local tissue disposition of salicylates, J. Pharm. Pharmacol., 52, 929, 10.1211/0022357001774813
Meidan, 1998, Vesicular carriers for topical delivery, Acta Technol. Legis. Medic., 9, 1
Meidan, 1998, Low intensity ultrasound as a probe to elucidate the relative follicular contribution to total transdermal absorption, Pharm. Res., 15, 85, 10.1023/A:1011956905388
Menczel, 1995, Delipidization of the cutaneous permeability barrier and percutaneous penetration, 383
Menon, 1994, High-frequency sonophoresis: permeation pathways and structural basis for enhanced permeation, Skin Pharmacol., 7, 130, 10.1159/000211287
Menon, 1998, Ultrastructural effects of some solvents and vehicles on the stratum corneum and other skin components: evidence for an ‘extended mosaic-partitioning model of the skin barrier’, 727
Merino, 1999, Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil, Pharm. Res., 16, 758, 10.1023/A:1018841111922
Mezei, 1992, Biodisposition of liposome-encapsulated active ingredients applied on the skin, 206
Mezei, 1980, Liposomes: a selective drug delivery system for the topical route of administration. I. Lotion dosage form, Life Sci., 26, 1473, 10.1016/0024-3205(80)90268-4
Mezei, 1982, Liposomes: a selective drug delivery system for the topical route of administration: gel dosage form, J. Pharm. Pharmacol., 34, 473, 10.1111/j.2042-7158.1982.tb04767.x
Miller, 1990, Transdermal iontophoresis of gonadotropin releasing hormone and two analogues, J. Pharm. Sci., 79, 490, 10.1002/jps.2600790607
Misra, 1999, Needle-free non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus, Vaccine, 18, 517, 10.1016/S0264-410X(99)00212-1
Mitragotri, 2000, Synergistic effect of enhancers for transdermal drug delivery, Pharm. Res., 17, 1354, 10.1023/A:1007522114438
Mitragotri, 1995, 103
Mitragotri, 1995, Ultrasound-mediated transdermal protein delivery, Science, 269, 850, 10.1126/science.7638603
Mitragotri, 1996, Transdermal drug delivery using low-frequency sonophoresis, Pharm. Res., 13, 411, 10.1023/A:1016096626810
Mitragotri, 2000, Transdermal extraction of analytes using low-frequency ultrasound, Pharm. Res., 17, 466, 10.1023/A:1007537222591
Mitragotri, 2000, Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels, J. Appl. Phys., 89, 961
Mitragotri, 1995, A mechanistic study of ultrasonically enhanced transdermal drug delivery, J. Pharm. Sci., 84, 697, 10.1002/jps.2600840607
Mitragotri, 2000, Determination of threshold energy dose for ultrasound-induced transdermal drug transport, J. Control. Rel., 63, 41, 10.1016/S0168-3659(99)00178-9
Mitragotri, 2000, Low frequency sonophoresis: a noninvasive method of drug delivery and diagnostics, Biotech. Prog., 16, 488, 10.1021/bp000024+
Mitragotri, 2000, Synergistic effect of low-frequency ultrasound and sodium lauryl sulphate on transdermal transport, J. Pharm. Sci., 89, 892, 10.1002/1520-6017(200007)89:7<892::AID-JPS6>3.0.CO;2-V
Murthy, 1999, Magnetophoresis: an approach to enhance transdermal drug diffusion, Pharmazie, 54, 377
Naik, 2000, Transdermal drug delivery: overcoming the skin’s barrier function, PSTT, 3, 318
Nyqvist-Mayer, 1986, Drug release studies on an oil–water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase, J. Pharm. Sci., 75, 365, 10.1002/jps.2600750409
Oldenburg, 1995, Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin, J. Pharm. Sci., 84, 915, 10.1002/jps.2600840803
Ongpipattanakul, 1991, Evidence that oleic acid exists in a separate phase within stratum corneum lipids, Pharm. Res., 8, 350, 10.1023/A:1015845632280
Paul, 1995, Transdermal immunization with large proteins by means of ultradeformable drug carriers, Eur. J. Immunol., 25, 3521, 10.1002/eji.1830251248
Peck, 1996, Quantitative description of the effect of molecular size upon electroosmotic flux enhancement during iontophoresis for a synthetic membrane and human epidermal membrane, J. Pharm. Sci., 85, 781, 10.1021/js950044j
Pellett, 1997, The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro, J. Control. Rel, 46, 205, 10.1016/S0168-3659(96)01595-7
Pellett, 1994, Effect of supersaturation on membrane transport: 2. Piroxicam, Int. J. Pharm., 111, 1, 10.1016/0378-5173(94)90395-6
Pellett, 1997, Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique, Int. J. Pharm., 151, 91, 10.1016/S0378-5173(97)04897-7
Perez-Cullell, 2000, Influence of the fluidity of liposome compositions on percutaneous absorption, Drug Del., 7, 7, 10.1080/107175400266731
Pikal, 1992, The role of electroosmosis in transdermal iontophoresis, Adv. Drug Del. Rev., 9, 201, 10.1016/0169-409X(92)90024-K
Planas, 1992, Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local pain insensitivity by anesthetic liposomes, Anesth. Analg., 75, 615, 10.1213/00000539-199210000-00027
Prausnitz, 1999, A practical assessment of transdermal drug delivery by skin electroporation, Adv. Drug Del. Rev., 35, 61, 10.1016/S0169-409X(98)00063-5
Prausnitz, 1993, Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery, Proc. Natl. Acad. Sci. USA, 90, 10504, 10.1073/pnas.90.22.10504
Prausnitz, 1995, Transdermal delivery of heparin by skin electroporation, Biotechnology, 13, 1205, 10.1038/nbt1195-1205
Prausnitz, 1996, Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures, J. Pharm. Sci., 85, 1363, 10.1021/js960020s
Raghavan, 2000, Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate, Int. J. Pharm., 193, 231, 10.1016/S0378-5173(99)00345-2
Reddy, 2000, Chirality and its implications in transdermal drug development, Crit. Rev. Ther. Drug Carrier Syst., 17, 285, 10.1615/CritRevTherDrugCarrierSyst.v17.i4.10
Regnier, 1999, Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation, Int. J. Pharm., 184, 147, 10.1016/S0378-5173(98)00085-4
Regnier, 1997, Parameters controlling topical delivery of oligonucleotides by electroporation, Drug Target., 5, 1
Regnier, 2000, Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin, J. Control. Rel., 67, 337, 10.1016/S0168-3659(00)00223-6
Riviere, 1995, Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology, J. Control. Rel., 36, 229, 10.1016/0168-3659(95)00036-8
Rowland, 2000, The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro, J. Control. Rel., 68, 157, 10.1016/S0168-3659(00)00242-X
Roy, 2000, Induction of antigen-specific CD8+T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine, Vaccine, 19, 764, 10.1016/S0264-410X(00)00302-9
Sage, 1995, Iontophoresis, 351
Santi, 1996, Reverse iontophoresis – parameters determining electroosmotic flow: 1. pH and ionic strength, J. Control. Rel., 38, 159, 10.1016/0168-3659(95)00115-8
Sarphie, 1997, Bioavailability following transdermal powdered delivery (TPD) of radiolabeled inulin to hairless guinea pigs, J Control. Rel., 47, 61, 10.1016/S0168-3659(96)01616-1
Schaefer, 1996, 235
Schreier, 1994, Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery, J. Control. Rel., 30, 1, 10.1016/0168-3659(94)90039-6
Schwarb, 1999, Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin, Pharm. Res., 16, 909, 10.1023/A:1018890422825
Scott, 1993, Transport of ionic species in skin: contribution of pores to the overall skin conductance, Pharm. Res., 10, 1699, 10.1023/A:1018909811672
Sentjurc, 1999, Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging, J. Control. Rel., 59, 87, 10.1016/S0168-3659(98)00181-3
Simonin, 1995, On the mechanisms of in vitro and in vivo phonophoresis, J. Control. Rel., 33, 125, 10.1016/0168-3659(94)00075-6
Sims, 1990, Baseline studies on iontophoretic transport in hairless mouse skin: the effect of applied voltage drop and pH on the iontophoresis of a model weak electrolyte, J. Membr. Sci., 49, 305, 10.1016/S0376-7388(00)80645-6
Singh, 1998, Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis, Int. J. Pharm., 166, 157, 10.1016/S0378-5173(98)00045-3
Sinha, 2000, Permeation enhancers for drug delivery, Drug. Devel. Ind. Pharm., 26, 1131, 10.1081/DDC-100100984
1995
Smith, 2000, Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin, Int. J. Pharm., 210, 69, 10.1016/S0378-5173(00)00561-5
Stott, 1996, Characterisation of complex coacervates of some tricyclic antidepressants and evaluation of their potential for enhancing transdermal flux, J. Control. Rel., 41, 215, 10.1016/0168-3659(96)01328-4
Stott, 1998, Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen, J. Control. Rel., 50, 297, 10.1016/S0168-3659(97)00153-3
Stott, 2001, Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: a melting point depression effect, Int. J. Pharm., 219, 161, 10.1016/S0378-5173(01)00645-7
Svedman, 1996, Passive drug diffusion via standardized skin mini-erosion; Methodological aspects and clinical findings with new device, Pharm. Res., 13, 1354, 10.1023/A:1016021900286
Tachibana, 1992, Transdermal delivery of insulin to aloxan-diabetic rabbits by ultrasound exposure, Pharm. Res., 9, 952, 10.1023/A:1015869420159
Tacket, 1999, Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device, Vaccine, 17, 2826, 10.1016/S0264-410X(99)00094-8
Tamada, 1995, Measurement of glucose in diabetic subjects using non-invasive transdermal extraction, Nature Med., 1, 1198, 10.1038/nm1195-1198
Teissie, 1999, Electropermeabilization of cell membranes, Adv. Drug Deliv. Rev., 35, 3, 10.1016/S0169-409X(98)00060-X
Touitou, E., 1996. Compositions for applying active substances to or through the skin. US patent, 5,540,934.
Touitou, E., 1998. Composition for applying active substances to or through the skin. US patent, 5,716,683.
Touitou, 2000, Ethosomes – novel vesicular carriers for enhanced delivery: characterisation and skin penetration properties, J. Control. Rel., 65, 403, 10.1016/S0168-3659(99)00222-9
Touitou, 2000, Enhanced delivery of drugs into and across the skin by ethosomal carriers, Drug Dev. Res., 50, 406, 10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M
Touitou, 2000, Enhanced delivery of drugs into and across the skin by ethosomal carriers, Drug Devel. Res., 50, 406, 10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M
Touitou, 1998, Methods of quantitative determination of drug localized in the skin, J. Control. Rel., 56, 7, 10.1016/S0168-3659(98)00060-1
Touitou, 1994, Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers, Int. J. Pharm., 103, 131, 10.1016/0378-5173(94)90093-0
Tschan, 1997, Sebaceous-gland deposition of isotretinoin after topical application: An in vitro study using human facial skin, Skin Pharmacol., 10, 126, 10.1159/000211477
Ueda, 1995, Skin penetration-enhancing effects of drugs by phonophoresis, J. Control. Rel., 37, 291, 10.1016/0168-3659(95)00087-9
Valenta, 2000, The dermal delivery of lignocaine: influence of ion pairing, Int. J. Pharm., 197, 77, 10.1016/S0378-5173(99)00453-6
Vanbever, 1996, Transdermal delivery of fentanyl by electroporation II. Mechanisms involved in drug transport, Pharm. Res., 9, 1360, 10.1023/A:1016073917125
Vanbever, 1997, Macromolecules as novel transdermal transport enhancers for skin electroporation, Pharm. Res., 14, 638, 10.1023/A:1012161313701
Vanbever, 1995, Factors affecting transdermal delivery of metoprolol by electroporation, Bioelectrochem. Bioenerg., 38, 223, 10.1016/0302-4598(95)01830-8
Vanbever, 1998, Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation, J. Control. Rel., 50, 225, 10.1016/S0168-3659(97)00147-8
Vanbever, 1999, In vivo efficacy and safety of skin electroporation, Adv. Drug Del. Rev., 35, 77, 10.1016/S0169-409X(98)00064-7
Vanderzanden, 1998, DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge, Virology, 246, 134, 10.1006/viro.1998.9176
Wang, 2000, Effect of sodium dodecyl sulphate on iontophoresis of hydrocortisone across hairless mouse skin, Pharm. Dev. T., 5, 533, 10.1081/PDT-100102036
Wang, 1997, Transdermal delivery of cyclosporin-A coevaporate using electroporation technique, Drug Dev. Ind. Pharm., 23, 657, 10.3109/03639049709150766
Waranuch, 1998, Controlled topical delivery of cyclosporin-A from nonionic liposomal formulations: mechanistic aspects, J. Liposome Res., 8, 225, 10.3109/08982109809035528
Wearley, 1989, Iontophoresis facilitated transdermal delivery of verapamil. II. Factors affecting reversibility of skin permeability, J. Control. Rel., 9, 231, 10.1016/0168-3659(89)90091-6
Weaver, 2000, Electroporation of cells and tissues, IEEE Trans. Plasma Sci., 28, 24, 10.1109/27.842820
Weaver, 1997, Heparin alters transdermal transport associated with electroporation, Biochem. Biophys. Res. Commun., 234, 637, 10.1006/bbrc.1997.6701
Weiner, 1998, Targeted follicular delivery of macromolecules via liposomes, Int. J. Pharm., 162, 29, 10.1016/S0378-5173(97)00409-2
Wester, 1995, Penetration enhancement by skin hydration, 21
Williams, 1991, Terpenes and the lipid–protein partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17, 10.1023/A:1015813803205
Williams, 1991, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (estradiol) and hydrophilic (5-fluorouracil) drugs, Int. J. Pharm., 74, 157, 10.1016/0378-5173(91)90232-D
Zewert, 1995, Transdermal transport of DNA antisense oligonucleotides by electroporation, Biochem. Biophys. Res. Commun., 212, 286, 10.1006/bbrc.1995.1968
Zewert, 1999, Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule, Bioelectrochem. Bioenerg., 49, 11, 10.1016/S0302-4598(99)00056-2
Zhang, 1996, Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin ageing and other diseases, Biochem. Biophys. Res. Commun., 220, 633, 10.1006/bbrc.1996.0455